Media store

Media Releases

Published on: 17 April 2018

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Roche today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Hemlibra® (emicizumab-kxwh) for people with haemophilia A without factor VIII ...

Published on: 16 April 2018

Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline

Roche announced today that new data on its approved and investigational medicines for neurological conditions will be presented during the 70th American Academy of Neurology (AAN) Annual Meeting from ...

Published on: 6 April 2018

Roche completes acquisition of Flatiron Health

Roche today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Flatiron Health is a ...

Upcoming Events

All

26April

First quarter sales 2018

(GMT)

Basel

26July

Half year results 2018

(GMT)

Basel

17October

Third quarter sales 2018

(GMT)

Basel

Images

Topics

Media contacts

For media requests

+41 61 688 8888

Media Relations Team

For all general enquiries

Please call the Roche switchboard on
Phone:+41 61 688 11 11